Sandrine Oziel-Taieb: Hematological Toxicity Management During Lu-Dotatate
Sandrine Oziel-Taieb, Medical Oncologist at the Paoli Calmettes Institute, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in EJNMMI, adding:
“Our national survey on hematological toxicity management during Lu Dotatate is now published in the European Journal of Nuclear Medicine and Molecular Imaging.
The LutaVire survey, conducted under the auspices the GTE, SFMN and endocan renaten network, highlights substantial real-world heterogeneity in how clinicians manage thrombocytopenia and long term bone marrow safety during PRRT, and underscores the need for harmonized, individualized monitoring guidelines.
Thank you to all 40 expert physicians who contributed, and to my co autors Magalie Haissaguerre, Catherine Ansquer, Emmanuel Deshayes, and Ghoufrane Tlili.”
Title: Managing hematological toxicity in Lu-DOTATATE for NET patients: a national survey from the French group of endocrine tumors (GTE) on the clinical need for harmonized monitoring strategies
Authors: S. Oziel-Taieb, C. Ansquer, G. Tlili, E. Deshayes, M. Haissaguerre
Stay updated on all scienntific advances with Hemostasis Today.
-
Sep 5, 2026, 14:43Nandini Pethe: How Digital Logs Help Recognize Pediatric von Willebrand Disease
-
Sep 5, 2026, 14:36Aremu David: Solving Tic-Tac-Toe in 7ms: How I Built Nine
-
Sep 5, 2026, 13:05Sheharyar Raza: Threshold-Based Transfusion in Sickle Cell Disease
-
Sep 5, 2026, 12:34Stijn Wigerinck: A Practical Roadmap for Eosinophilia and Hypereosinophilia
-
Sep 5, 2026, 11:51Alejandro González Veliz: Why Secondary Prevention Matters After PCI
-
Sep 5, 2026, 11:39Julie Rayes: Sepsis Rewrites the Role of Mast Cells in Thrombosis
-
Sep 5, 2026, 11:30Shirley D’Sa: Chemoimmunotherapy in Cold Agglutinin Disease and WM-Associated CAS
-
Sep 5, 2026, 11:29Dilini Christina Ranasinghe: An Exception to the ‘Universal Donor’ – Bombay (Oh)
-
Sep 5, 2026, 11:10Amanda Stahl: Integrating Psychosocial Care Into Comprehensive Hemophilia Treatment